Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin

Journal of Physiology and Pharmacology

Volumn 63, Issue 6, 2012, Pages 649-659

  Martin, A I ^a   Nieto Bona, M P ^b   Castillero, E ^a   Fernandez Galaz, C ^a   Lopez Menduina, M ^a   Gomez Sanmiguel, A B ^a   Gomez Moreira, C ^a   Villanua, M Angeles ^a   Lopez Calderon, A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Cyclooxygenase 2; Gastrocnemius muscle; Lipopolysaccharide; Meloxicam; MyoD; Myogenin; Myostatin; Sepsis; Skeletal muscle

Indexed keywords

ATROGIN 1; CYCLOOXYGENASE 2; MELOXICAM; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; MYOD PROTEIN; MYOGENIC FACTOR; MYOGENIN; TRANSCRIPTION FACTOR PAX7;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; MALE; MOLECULAR EVOLUTION; MYOSITIS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIC REGULATORY FACTORS; PAIRED BOX TRANSCRIPTION FACTORS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKP CULLIN F-BOX PROTEIN LIGASES; THIAZINES; THIAZOLES; TIME FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 84873431214     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit Care Med 2009; 37: S354-S367.
2. Argiles JM, Busquets S, Toledo M, Lopez-Soriano FJ. The role of cytokines in cancer cachexia. Curr Opin Support Palliat Care 2009; 3: 263-268.
3. Granado M, Martin AI, Villanua MA, Lopez-Calderon A. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation. Am J Physiol Endocrinol Metab 2007; 292: E1656-E1665.
4. Poulsen JP, Moller K, Jensen CV, Weisdorf S, Kehlet H, Perner A. Effect of transcutaneous electrical muscle stimulation on muscle volume in patients with septic shock. Crit Care Med 2011; 39: 456-461.
5. Klaude M, Mori M, Tjader I, Gustafsson T, Wernerman J, Rooyackers O. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci (Lond) 2012; 122: 133-142.
6. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294: 1704-1708.
7. Costelli P, Muscaritoli M, Bonetto A, et al. Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest 2008; 38: 531-538.
8. Testa M, Rocca B, Spath L, et al. Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents. J Appl Physiol 2007; 103: 1412-1418.
9. Hussey HJ, Tisdale MJ. Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model. Int J Cancer 2000; 87: 95-100.
10. Lundholm K, Daneryd P, Korner U, Hyltander A, Bosaeus I. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 2004; 24: 505-512.
11. Hitt A, Graves E, McCarthy DO. Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumorbearing mice. Res Nurs Health 2005; 28: 56-66.
12. Novak ML, Billich W, Smith SM, et al. COX-2 inhibitor reduces skeletal muscle hypertrophy in mice. Am J Physiol Regul Integr Comp Physiol 2009; 296: R1132-R1139.
13. Bondesen BA, Mills ST, Kegley KM, Pavlath GK. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 2004; 287: C475-C483.
14. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 2005; 288: R345-R353.
15. Martin AI, Lopez-Menduina M, Castillero E, Granado M, Villanua MA, Lopez-Calderon A. Cyclooxygenase-2 activation by endotoxin mediates the decrease in IGF1, but not in IGFBP3 gene expression in the liver. J Endocrinol 2008; 198: 385-394.
16. Li B, Li YM, Li X, et al. COX-2 inhibition improves immune system homeostasis and decreases liver damage in septic rats. J Surg Res 2009; 157: 43-47.
17. Granado M, Martin AI, Lopez-Menduina M, Lopez-Calderon A, Villanua MA. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. Am J Physiol Endocrinol Metab 2008; 294: E131-E141.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
19. Minnaard R, Wagenmakers AJ, Combaret L, et al. Ubiquitinproteasome-dependent proteolytic activity remains elevated after zymosan-induced sepsis in rats while muscle mass recovers. Int J Biochem Cell Biol 2005; 37: 2217-2225.
20. Dehoux MJ, van Beneden RP, Fernandez-Celemin L, Lause PL, Thissen JP. Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett 2003; 544: 214-217.
21. Wray CJ, Mammen JM, Hershko DD, Hasselgren PO. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 2003; 35: 698-705.
22. Reardon KA, Davis J, Kapsa RM, Choong P, Byrne E. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 2001; 24: 893-899.
23. Wieteska-Skrzeczynska W, Grzelkowska-Kowalczyk K, Jank M, Maciejewski H. Transcriptional dysregulation of skeletal muscle protein metabolism in streptozotocin-diabetic mice. J Physiol Pharmacol 2009; 60(Suppl 1): 29-36.
24. Smith IJ, Aversa Z, Alamdari N, Petkova V, Hasselgren PO. Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle. J Cell Biochem 2010; 111: 1059-1073.
25. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000; 289: 2363-2366.
26. Pajak B, Orzechowska S, Pijet B, Pijet M, Pogorzelska A, Gajkowska B, Orzechowski A. Crossroads of cytokine signaling-the chase to stop muscle cachexia. J Physiol Pharmacol 2008; 59 (Suppl 9): 251-264.
27. Palacios D, Mozzetta C, Consalvi S, et al. TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010; 7: 455-469.
28. Kuang S, Charge SB, Seale P, Huh M, Rudnicki MA. Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J Cell Biol 2006; 172: 103-113.
29. Zammit PS, Golding JP, Nagata Y, Hudon V, Partridge TA, Beauchamp JR. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J Cell Biol 2004; 166: 347-357.
30. Toledo M, Busquets S, Ametller E, Lopez-Soriano FJ, Argiles JM. Sirtuin 1 in skeletal muscle of cachectic tumourbearing rats: a role in impaired regeneration? J Cachexia Sarcopenia Muscle 2011; 2: 57-62.
31. Castillero E, Marin AI, Lopez-Menduina M, Granado M, Villanua MA, Lopez-Calderon A. IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting. Mol Cell Endocrinol 2009; 309: 8-16.
32. Pessina P, Conti V, Pacelli F, et al. Skeletal muscle of gastric cancer patients expresses genes involved in muscle regeneration. Oncol Rep 2010; 24: 741-745.
33. Martinez PF, Okoshi K, Zornoff LA, et al. Chronic heart failure-induced skeletal muscle atrophy, necrosis, and changes in myogenic regulatiory factors. Med Sci Monit 2010; 16: BR374-BR383.
34. Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One 2009; 4: e4973.
35. Jogo M, Shiraishi S, Tamura TA. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase. FEBS Lett 2009; 583: 2715-2719.
36. Srikuea R, Pholpramool C, Kitiyanant Y, Yimlamai T. Satellite cell activity in muscle regeneration after contusion in rats. Clin Exp Pharmacol Physiol 2010; 37: 1078-1086.
37. Mendias CL, Tatsumi R, Allen RE. Role of cyclooxygenase-1 and-2 in satellite cell proliferation, differentiation, and fusion. Muscle Nerve 2004; 30: 497-500.
38. Bondesen BA, Mills ST, Pavlath GK. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol 2006; 290: C1651-C1659.
39. 2alpha. J Appl Physiol 2006; 101: 1215-1221.
40. Machida M, Takemasa T. Ibuprofen administration during endurance training cancels running-distance-dependent adaptations of skeletal muscle in mice. J Physiol Pharmacol 2010; 61: 559-563.
41. Paulsen G, Egner IM, Drange M, et al. A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise. Scand J Med Sci Sports 2010; 20: e195-e207.
42. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8: 349-361.